Literature DB >> 20684566

Enthalpic efficiency of ligand binding.

György G Ferenczy1, György M Keseru.   

Abstract

The thermodynamics of ligand-protein binding has received much attention recently. In the present contribution we focus on the enthalpic component of binding. The dissociation constant, pK(d), was decomposed into enthalpic and entropic components (pK(d) = pK(H) + pK(S)), and pK(H), defined as pK(H) = -ΔH/(2.303·RT) was used to characterize the enthalpy contribution to binding. It was found that the maximal achievable pK(H) decreases with increasing molecular size. This is in contrast to maximal pK(d) that increases with molecular size until it achieves a plateau. Size-independent enthalpic efficiency (SIHE) was defined as SIHE = pK(H)/40·HA(0.3), with HA being the number of heavy atoms. SIHE allows a size unbiased comparative binding characterization of compounds. It can find use in hit and lead selection and also in monitoring optimization in drug discovery programs. The physical background of decreasing maximal pK(H) with molecular size is discussed, and its consequences to drug discovery are analyzed. It is concluded that the feasibility of simultaneous optimization of affinity and enthalpy diminishes with increasing molecular size. Consequently, binding thermodynamics considerations are to be applied primarily in hit prioritization and hit-to-lead optimization.

Mesh:

Substances:

Year:  2010        PMID: 20684566     DOI: 10.1021/ci100125a

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  11 in total

Review 1.  Finding the sweet spot: the role of nature and nurture in medicinal chemistry.

Authors:  Michael M Hann; György M Keserü
Journal:  Nat Rev Drug Discov       Date:  2012-04-30       Impact factor: 84.694

Review 2.  The influence of the 'organizational factor' on compound quality in drug discovery.

Authors:  Paul D Leeson; Stephen A St-Gallay
Journal:  Nat Rev Drug Discov       Date:  2011-09-30       Impact factor: 84.694

Review 3.  Entropy-enthalpy compensation: role and ramifications in biomolecular ligand recognition and design.

Authors:  John D Chodera; David L Mobley
Journal:  Annu Rev Biophys       Date:  2013       Impact factor: 12.981

Review 4.  The role of ligand efficiency metrics in drug discovery.

Authors:  Andrew L Hopkins; György M Keserü; Paul D Leeson; David C Rees; Charles H Reynolds
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

5.  Thermodynamics of ligand binding and efficiency.

Authors:  Charles H Reynolds; M Katharine Holloway
Journal:  ACS Med Chem Lett       Date:  2011-03-23       Impact factor: 4.345

6.  Sustainable synthesis and automated deposition: an accessible discovery screening library of fragment-like purines.

Authors:  Christoph Kamper; Katharina Korpis; Edgar Specker; Lennart Anger; Martin Neuenschwander; Patrick J Bednarski; Andreas Link
Journal:  Mol Divers       Date:  2012-08-14       Impact factor: 2.943

Review 7.  Thermodynamic studies for drug design and screening.

Authors:  Nichola C Garbett; Jonathan B Chaires
Journal:  Expert Opin Drug Discov       Date:  2012-03-08       Impact factor: 6.098

8.  Determination of the endothelin-1 recognition sites of endothelin receptor type A by the directed-degeneration method.

Authors:  Seong-Gu Han; Sanghwan Ko; Won-Kyu Lee; Sang Taek Jung; Yeon Gyu Yu
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

9.  Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A 2A adenosine receptor binding site.

Authors:  Pierre Matricon; Anirudh Ranganathan; Eugene Warnick; Zhan-Guo Gao; Axel Rudling; Catia Lambertucci; Gabriella Marucci; Aitakin Ezzati; Mariama Jaiteh; Diego Dal Ben; Kenneth A Jacobson; Jens Carlsson
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

10.  S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth.

Authors:  Patrick Casara; James Davidson; Audrey Claperon; Gaëtane Le Toumelin-Braizat; Meike Vogler; Alain Bruno; Maïa Chanrion; Gaëlle Lysiak-Auvity; Thierry Le Diguarher; Jérôme-Benoît Starck; Ijen Chen; Neil Whitehead; Christopher Graham; Natalia Matassova; Pawel Dokurno; Christopher Pedder; Youzhen Wang; Shumei Qiu; Anne-Marie Girard; Emilie Schneider; Fabienne Gravé; Aurélie Studeny; Ghislaine Guasconi; Francesca Rocchetti; Sophie Maïga; Jean-Michel Henlin; Frédéric Colland; Laurence Kraus-Berthier; Steven Le Gouill; Martin J S Dyer; Roderick Hubbard; Mike Wood; Martine Amiot; Gerald M Cohen; John A Hickman; Erick Morris; James Murray; Olivier Geneste
Journal:  Oncotarget       Date:  2018-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.